109 Brain Surgeries, 95% Accuracy: How a Robot Is Changing Epilepsy Treatment in Seoul

Samsung Medical Center has used its ROSA surgical robot in 109 epilepsy procedures, cutting electrode placement time to a third of the pre-robot duration with under 1% complications.

Key Takeaways

  • Samsung Medical Center has performed 109 robotic epilepsy surgeries using its ROSA system since introducing it in 2021.
  • Electrode placement accuracy has stayed above 95%, with complication rates below 1%.
  • The robot cut electrode placement time to roughly one-third of the pre-robot duration.
  • An in-house digital twin system called SESTA simulates electrode trajectories before surgery to catch risky paths in advance.
  • The procedure, stereoelectroencephalography, maps seizure origin points in patients whose epilepsy does not respond to medication.

109 Brain Surgeries, 95% Accuracy: How a Robot Is Changing Epilepsy Treatment in Seoul

Ten to twenty hair-thin electrodes have to reach precise points deep inside a patient's brain before doctors can even locate where a seizure starts. At Samsung Medical Center in Seoul, that job increasingly belongs to a robot. The hospital announced on November 16, 2026, that its ROSA surgical robot has now been used in 109 procedures for intractable epilepsy, maintaining placement accuracy above 95% since its introduction in 2021.

The procedure, called stereoelectroencephalography, involves threading electrodes through small holes in the skull to map which part of the brain is triggering seizures that medication cannot control. Surgeons use that mapping to decide where to operate or, in some cases, confirm that surgery is not needed at all.

Faster, Fewer Complications

Samsung Medical Center says ROSA has cut electrode placement time to roughly one-third of what it took before the robot was introduced, while keeping the complication rate below 1%. Lee Seung-hoon, a neurosurgery professor at the hospital, credited the robot with reducing both operating time and the risk of complications such as brain hemorrhage, calling it a direct benefit to the burden placed on patients.

Supporting the robot is SESTA, an in-house digital twin system that simulates electrode trajectories before the actual operation begins. By modeling the placement virtually first, surgeons can catch risky paths, ones that might nick a blood vessel or miss the target region, before a single electrode touches the patient. Seo Dae-won, head of the hospital's neuroscience center, has overseen the program's expansion since its launch.

A Narrow but High-Stakes Use Case for Surgical Robots

Epilepsy electrode placement is a smaller surgical niche than the hip replacements or prostatectomies that dominate robotic surgery headlines, but it is exactly the kind of procedure where robotic precision has an outsized payoff. Human hands, however skilled, introduce small tremors and positioning drift over a long procedure; a robot holding steady across 10 to 20 separate electrode insertions removes that variable entirely.

The reported sub-1% complication rate stands out against historical rates for manual stereoelectroencephalography, where brain hemorrhage risk has been cited in medical literature at several percentage points depending on the center and patient population. If Samsung Medical Center's figures hold up across a larger patient pool, it strengthens the case for robot-assisted electrode placement becoming standard rather than a specialty offering limited to a handful of major hospitals.

The hospital has not disclosed plans to expand ROSA's caseload beyond epilepsy surgery, but the five years of data behind the 109-case milestone give Samsung Medical Center a track record other hospitals weighing similar robotic investment will likely scrutinize closely, according to Seoul Economic Daily.

Category: Surgical Robotics

Tags: Surgical Robotics Samsung Medical Center ROSA robot epilepsy surgery stereoelectroencephalography

Related Articles

Frequently Asked Questions

What is the ROSA robot used for at Samsung Medical Center?

ROSA assists surgeons in placing 10 to 20 electrodes deep in the brain during stereoelectroencephalography, a procedure used to locate the origin of seizures in intractable epilepsy patients.

How accurate is the ROSA robot?

Samsung Medical Center reports placement accuracy above 95% across 109 procedures performed since 2021.

What is the complication rate with robotic electrode placement?

The hospital reports a complication rate below 1%, alongside a reduction in operating time to roughly a third of the pre-robot duration.

What is the SESTA system mentioned alongside ROSA?

SESTA is an in-house digital twin tool that simulates electrode placement before surgery, helping surgeons avoid risky trajectories ahead of the actual procedure.